My Cart

latent GDF-8

latent GDF-8 Overview

English NameGrowth/differentiation factor 8Approved Drugs0
Drugs in Clinical Trials6Target SynonymMSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
Highest Development StageNDA/BLA
English NameGrowth/differentiation factor 8
Target SynonymMSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
Approved Drugs0
Drugs in Clinical Trials6
Highest Development StageNDA/BLA

Product Inquiry

latent GDF-8 Background

Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

latent GDF-8 Synonyms

latent GDF-8

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Talditercept alfaRO-7239361; BMS-986089; RG-6206; BHV-2000Phase 3 ClinicalBristol-Myers Squibb CompanyMuscular Dystrophy, Duchenne; Neuromuscular Diseases; Muscular Atrophy, Spinal
Details
RO-7204239GYM-329; RO-7204239; RG-6237; RG-70240Phase 3 ClinicalF. Hoffmann-La Roche Ltd, Chugai Pharmaceutical Co LtdMuscular Dystrophy, Facioscapulohumeral; Muscular Atrophy, Spinal
Details
TrevogrumabREGN-1033; REGN1033; SAR-391786; GDF8Phase 2 ClinicalRegeneron Pharmaceuticals IncMyositis, Inclusion Body; Obesity; Sarcopenia
Details
AAV1-FS344AAV1-Follistatin; AAV1-FS344Phase 2 ClinicalNationwide Children'S HospitalBecker muscular dystrophy; Myositis, Inclusion Body; Muscular Dystrophy, Duchenne
Details
KER-065KER-065; RKER-065Phase 1 ClinicalKeros Therapeutics IncNeuromuscular Diseases; Obesity
Details
HS135HS-135Phase 1 Clinical35Pharma IncHypertension, Pulmonary; Heart Failure, Diastolic; Pulmonary Arterial Hypertension
Details
  • Overview
  • Product Inquiry
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland